SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emami inches up after its arm disposes entire stake in Fravin Pty

21 Dec 2020 Evaluate

Emami is currently trading at Rs. 419.40, up by 0.30 points or 0.07% from its previous closing of Rs. 419.10 on the BSE.

The scrip opened at Rs. 418.00 and has touched a high and low of Rs. 422.85 and Rs. 413.00 respectively. So far 10226 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 461.45 on 01-Dec-2020 and a 52 week low of Rs. 140.85 on 30-Mar-2020.

Last one week high and low of the scrip stood at Rs. 432.70 and Rs. 411.00 respectively. The current market cap of the company is Rs. 18682.91 crore.

The promoters holding in the company stood at 53.86%, while Institutions and Non-Institutions held 37.56% and 8.59% respectively.

Emami’s wholly owned subsidiary -- Emami International FZE, Sharjah, has disposed its entire stake of 85% held in Fravin Pty, Australia, consequently, Fravin Pty and its step down subsidiary companies, namely Diamond Bio Tech Laboratories Pty and Abache Pty have ceased to be subsidiary Companies of Emami.

Fravin Pty, Diamond Bio Tech Laboratories Pty and Abache Pty were inoperative and there was no contribution in the consolidated revenue/ turnover of Emami; therefore, there will be no impact on the operations/ financials of the Company.

Emami is the flagship company of the Emami Group and engaged in manufacturing products under various categories namely Hair Care, Skin Creams and Lotions, Talcum Powder and ayurvedic health care products.

Emami Share Price

424.25 5.70 (1.36%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Hindustan Unilever 2155.60
Godrej Consumer Prod 1078.30
Dabur India 436.40
Colgate Palmol. (I) 1939.50
P&G Hygiene 9801.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×